Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CMPS
CMPS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMPS News
Compass Pathways Appoints New Board Member
2d ago
Newsfilter
Compass Pathways to Attend Jefferies Global Healthcare Conference
4d ago
Newsfilter
FDA Leadership Change Boosts Psychedelic Drug Prospects
May 18 2026
stocktwits
Trump's Executive Order Accelerates Psychedelic Drug Development
May 18 2026
Newsfilter
Compass Pathways to Attend RBC Healthcare Conference
May 14 2026
Newsfilter
COMPASS Pathways Q1 2026 Earnings Call Insights
May 13 2026
seekingalpha
COMPASS Pathways Q1 2026 Earnings Beat Expectations
May 13 2026
seekingalpha
Compass Pathways Secures FDA NDA Rolling Review Approval
May 13 2026
Newsfilter
COMPASS Pathways to Announce Q1 Earnings on May 13
May 12 2026
seekingalpha
Compass Pathways to Release Q1 Financial Results on May 13, 2026
May 06 2026
Newsfilter
COMPASS PATHWAYS PLC: JEFFERIES BEGINS COVERAGE WITH A BUY RATING AND TARGET PRICE OF $18
May 04 2026
moomoo
CMPS Stock Surges 41% This Week, Poised for Record Gains
Apr 24 2026
stocktwits
Compass Secures FDA Priority Review Support for COMP360
Apr 24 2026
Newsfilter
COMP360 Receives FDA Priority Review Voucher
Apr 24 2026
seekingalpha
FDA Accelerates Development of Psychedelic Treatments for Mental Health
Apr 24 2026
stocktwits
B. Riley Begins Coverage of Compass Pathways PLC with a Buy Rating and Sets Price Target at $17
Apr 24 2026
moomoo
Show More News
